Sign In
Buy SANA
$3.13
-0.120 (-3.69%)
At Close: Jul 31, 2026
Corient Private Wealth LLC Has $3.10 Million Stock Position in Sana Biotechnology, Inc. $SANA
03:40am, Monday, 22'nd Dec 2025
Corient Private Wealth LLC lifted its stake in shares of Sana Biotechnology, Inc. (NASDAQ: SANA) by 264.7% in the second quarter, according to its most recent Form 13F filing with the Securities and E
Data Demonstrate Potent in vivo Gene Editing of Hematopoietic Stem Cells (HSCs) in the Bone Marrow with Systemic Delivery in Preclinical Murine Models Using Fusogen Technology
Sana Biotechnology, Inc. (SANA) Presents at Evercore 8th Annual Healthcare Conference Transcript
05:03pm, Wednesday, 03'rd Dec 2025
Sana Biotechnology, Inc. (SANA) Presents at Evercore 8th Annual Healthcare Conference Transcript
Sana Biotechnology, Inc. (SANA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
05:43pm, Tuesday, 02'nd Dec 2025
Sana Biotechnology, Inc. (SANA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Sana Biotechnology to Present at December 2025 Investor Conferences
04:05pm, Monday, 24'th Nov 2025
SEATTLE, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webca
Top 3 Genomics Stocks to Consider for Your Portfolio
09:51am, Tuesday, 18'th Nov 2025
Genomics gains momentum as EDIT, SANA, and PACB emerge as standout picks amid rapid advances in sequencing and gene editing.
All You Need to Know About Sana (SANA) Rating Upgrade to Buy
01:01pm, Wednesday, 12'th Nov 2025
Sana (SANA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Sana Biotechnology: Scope Goes Beyond HIP-Modified Pancreatic Islet Cells For T1D
05:09pm, Thursday, 16'th Oct 2025
Sana Biotechnology, Inc. remains a Strong Buy, driven by progress in HIP-modified cell therapies for Type 1 Diabetes and B-cell-mediated disorders. Sana Biotechnology's HIP-modified islet cell therapy
Sana Biotechnology: A Big Winner In Waiting? Maybe, But It Won't Happen Overnight
04:18pm, Thursday, 16'th Oct 2025
Sana Biotechnology, Inc. surged after hedge fund manager Eric Jackson called it a potential "100-bagger" due to its pioneering diabetes cell therapy. Sana Biotechnology's breakthrough islet cell thera
Sana Biotech Stock — The Next '100-Bagger'?
12:15pm, Wednesday, 15'th Oct 2025
Sana Biotechnology, Inc. (NASDAQ:SANA) shares soared on Wednesday after outspoken stock promoter Eric Jackson named it as his latest potential “100-bagger.”
Sana Biotechnology, Inc. (SANA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
04:34pm, Monday, 08'th Sep 2025
Sana Biotechnology, Inc. (NASDAQ:SANA ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 11:30 AM EDT Company Participants Steven Harr - President, CEO & Director Conference C
Sana Biotechnology, Inc. (SANA) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
01:42am, Friday, 05'th Sep 2025
Sana Biotechnology, Inc. (NASDAQ:SANA ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 8:00 AM EDT Company Participants Steven Harr - President, CEO & Director Conference Call Pa
Sana Biotechnology, Inc. (SANA) Presents At Citi's Biopharma Back To School Conference Transcript
10:03pm, Tuesday, 02'nd Sep 2025
Sana Biotechnology, Inc. (NASDAQ:SANA ) Citi's Biopharma Back to School Conference September 2, 2025 3:15 PM EDT Company Participants Steven Harr - President, CEO & Director Conference Call Participan
IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies
08:00am, Thursday, 28'th Aug 2025
RESEARCH TRIANGLE PARK, N.C. and CAMBRIDGE, Mass.
Sana Biotechnology to Present at September 2025 Investor Conferences
04:05pm, Tuesday, 26'th Aug 2025
SEATTLE, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webc
